Legal Showdown: Federal Appeals Court Skeptical of HHS in High-Stakes Medicare Advantage Audit Battle on October 6, 2026 Posted by
GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences on October 6, 2026 Posted by
Unpacking the Disparities: How Maternal Health and Ethnicity Intersect in Autism Risk on October 6, 2026 Posted by
Shionogi Scales Up Rare Disease Ambitions with $2 Billion IntraBio Acquisition on October 5, 2026 Posted by
Celebrating Excellence: Honoring the Vital Contributions of Respiratory Therapists in Our Communities on October 5, 2026 Posted by
Pioneering a Shield Against the Silent Threat: The Launch of HENIPROTECT on October 5, 2026 Posted by
Legal Showdown: Federal Appeals Court Skeptical of HHS in High-Stakes Medicare Advantage Audit Battle on October 6, 2026 Posted by
GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences on October 6, 2026 Posted by
Unpacking the Disparities: How Maternal Health and Ethnicity Intersect in Autism Risk on October 6, 2026 Posted by
Posted in Digital Health Tools GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences on October 6, 2026
Posted in Medical Innovations AI-Driven Drug Discovery: Enveda Biosciences Secures $311 Million to Revolutionize Natural Product Chemistry on September 24, 2026
Posted in Medical Innovations AI-Driven Drug Discovery: Enveda Biosciences Secures $311M Series E to Revolutionize Pharmacognosy on September 24, 2026
Posted in Medical Innovations Tyra Biosciences’ Phase 2 Data for Dabogratinib: A Mixed Bag for Bladder Cancer Treatment on September 10, 2026
Posted in Medical Innovations Moonwalk Biosciences Secures $70M to Pivot Toward RNAi-Based Obesity Therapies on September 8, 2026
Posted in Medical Innovations Eli Lilly Expands Immunology Arsenal with Strategic Acquisition of Merida Biosciences on August 31, 2026
Posted in Digital Health Tools Jazz Pharmaceuticals Bolsters Epilepsy Franchise with $820 Million Acquisition of Actio Biosciences on August 16, 2026
Posted in Medical Innovations Argenx Bets Big on Immunology: A $2.2 Billion Acquisition of Forte Biosciences on July 28, 2026
Posted in Sleep Health Harmony Biosciences Charts a Path to 2030: Q1 2026 Earnings Signal Strategic Pivot Toward Long-Term Growth on June 3, 2026 rifanmuazin
Posted in Sleep Health Harmony Biosciences Charts a Path to 2030: Q1 2026 Performance and Strategic Expansion on May 24, 2026 rifanmuazin
